| 姚春筱.生脉注射液防治放射性肺损伤96例疗效分析[J].中华放射医学与防护杂志,2004,24(1):52-53 |
| 生脉注射液防治放射性肺损伤96例疗效分析 |
| Clinical analysis on Shengmai Injection in treating radiation pneumonia and pulmonary fibrosis |
| 投稿时间：2003-05-20 |
| DOI： |
| 中文关键词: 肺 损害 放射损伤 治疗 中药治疗 生脉注射液 |
| 英文关键词:Lung Lesion Radiation lesion Therapy Treatment by traditional Chinese medicine Shengmai Injection |
| 基金项目: |
|
| 摘要点击次数: 2798 |
| 全文下载次数: 2095 |
| 中文摘要: |
| 目的 观察生脉注射液对于放射治疗后放射性肺炎和肺纤维化的防治效果。方法 96例胸部肿瘤患者随机分为治疗组和对照组各48例,所有病例均接受根治性放疗,治疗组放疗同时应用生脉注射液40～60ml加入5%葡萄糖注射液中静脉点滴。结果 治疗组放射性肺炎和肺纤维化发生率分别是18.8%和16.7%;对照组的发生率分别为37.5%和35.4%,两组比较,差异有显著性(P<0.05)。结论 生脉注射液能够降低放射性肺损伤的发生率。 |
| 英文摘要: |
| Objective To study the effect of Shengmai Injection in treating radiation pneumonia and pulmonary fibrosis in the course of radiotherapy. Methods Altogether 96 cases were randomly and equally alloca |ted into a treatment group and a control group,48 cases each,All patients were treated with radical radiotherapy.The initial radiotherapy was using 10 MV X-rays at conventionally fractionated dose of 60-70 Gy.Patients of the control group were given conventional radiotherapy,and those of the treatment group were given both conventional radiotherapy and Shengmai Injection 40-60 ml by iv drip for 3-5 courses,10 days for each course. Results In the treatment group,the incidences of radiation pneumonia and pulmonary fibrosis were 18.8%,16.7%,respectively,whereas in the control group they were 37.5% and 35.4%,respectively.There were significant differences between the two groups ( P<0.05). Conclusion Shengmai Injection can decrease the incidences of radiation pneumonia and pulmonary fibrosis. |
| HTML 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|